Latest Breaking News On - Can fite biopharma - Page 4 : comparemela.com

StockNews.com Begins Coverage on Can-Fite BioPharma (NYSE:CANF)

Stock analysts at StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “hold” rating on the stock. Can-Fite BioPharma Stock Performance Shares of NYSE CANF opened at $2.09 on Tuesday. The company has a market capitalization […]

StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)

Investment analysts at StockNews.com initiated coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a note issued to investors on Tuesday. The firm set a “hold” rating on the stock. Can-Fite BioPharma Price Performance Can-Fite BioPharma stock opened at $2.09 on Tuesday. Can-Fite BioPharma has a one year low of $1.76 and […]

Long-term Complete Response to Can-Fite's Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific Journal

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it published an article.

Stock Analysts' New Coverage for April 22nd (AAU, AEZS, AGL, AIRG, AKRO, ATAT, AWX, BCML, BDL, BLPH)

Stock Analysts' New Coverage for April 22nd (AAU, AEZS, AGL, AIRG, AKRO, ATAT, AWX, BCML, BDL, BLPH)

Stock Analysts’ new coverage for Monday, April 22nd: StockNews.com initiated coverage on shares of Almaden Minerals (NYSE:AAU). The firm issued a sell rating on the stock. StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS) (TSE:AEZ). StockNews.com issued a sell rating on the stock. Citigroup Inc. started coverage on shares of agilon health (NYSE:AGL). They […]